Followers | 237 |
Posts | 10817 |
Boards Moderated | 0 |
Alias Born | 07/17/2006 |
Sunday, May 10, 2020 7:05:10 AM
Please forgive me for jumping in on this..I'm pretty sure Slim (my old buddy would agree)..
The knee jerk to this announcement is "Well Its more debt or a potential dilution...but actually it is a very good move by the CEO...Right now INSG is a guns a blazing as far a new accounts..But even though their revenues are increasing their earnings on a PPS are not..
Diagnosis...They are spending too much money...and they have one note they are currently servicing which is over 9%...With bonds trading at close to zero percent..9% is loan shark rates...So What the company is doing is borrowing at 3.25% and paying off a 9.6% loan and that is similar to a "carry trade" and the best one I can ever remember..The rise of PPS to $15 (temporarily) allowed the company to get 12 dollar plus conversion rate in the note to common stock..That is great...If they just floated a secondary they probably would have only been able to get $10/ share...What they got is not malignant dilution...And they can force conversion which they have in the past..
I believe the market will quickly understand the Convertible is the medicine the company needs to lower the cost of debt and improve the earnings..With the revenues looking great we should be heading for above $15 very soon...
JMO...":>) JL
Recent INSG News
- Inseego Voluntarily Pays-off and Terminates Asset-Backed Loan Facility to Improve Capital Structure Flexibility and Meaningfully Reduce Financing Costs • Business Wire • 04/18/2024 08:10:00 PM
- Inseego Corp. to Report First Quarter 2024 Financial Results on May 9, 2024 • Business Wire • 04/15/2024 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:17:01 PM
- Inseego reports Fourth Quarter and Full Year 2023 Financial Results and announces CEO transition • Business Wire • 02/21/2024 09:10:00 PM
- Inseego Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on Feburary 21, 2024 • Business Wire • 02/01/2024 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:22:30 PM
- Inseego Announces Reverse Stock Split • Business Wire • 01/22/2024 05:00:00 PM
- Inseego Appoints SVP of Global Channel Sales and Distribution • Business Wire • 11/29/2023 09:30:00 PM
- Inseego Announces the Availability of Its Next Generation 5G Fixed Wireless Access (FWA) Indoor Router at T-Mobile • Business Wire • 11/28/2023 03:30:00 PM
- Inseego Reports Third Quarter 2023 Financial Results • Business Wire • 11/02/2023 10:56:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:11:34 PM
- Inseego Reports Third Quarter 2023 Financial Results • Business Wire • 11/02/2023 08:01:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/30/2023 08:27:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:25:10 PM
- Inseego Corp. Appoints Chief Revenue Officer • Business Wire • 10/30/2023 08:10:00 PM
- Inseego Corp. to Report Third Quarter 2023 Financial Results on November 2, 2023 • Business Wire • 10/16/2023 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:14:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 12:33:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 12:32:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 12:32:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 12:32:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2023 12:31:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 08:13:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 08:54:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 08:10:10 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM